Literature DB >> 6297655

Ketoconazole.

R Hay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6297655      PMCID： PMC1499408          DOI： 10.1136/bmj.285.6342.584

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  9 in total

1.  Toxic hepatis during ketoconazole treatment.

Authors:  J K Heiberg; E Svejgaard
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-26

2.  Hepatitis and ketoconazole therapy.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-17

3.  Ketoconazole in paracoccidioidomycosis: efficacy of prolonged oral therapy.

Authors:  A Restrepo; D A Stevens; E Leiderman; J Fuentes; A Arana; R Angel; G Mejía; I Gómez
Journal:  Mycopathologia       Date:  1980-08-29       Impact factor: 2.574

4.  The treatment of patients with chronic mucocutaneous candidosis and candida onychomycosis with ketoconazole.

Authors:  R J Hay; Y M Clayton
Journal:  Clin Exp Dermatol       Date:  1982-03       Impact factor: 3.470

5.  Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients.

Authors:  I M Hann; H G Prentice; R Corringham; H A Blacklock; M Keaney; M Shannon; P Noone; E Gascoigne; J Fox; E Boesen; M Szawatkowski; A V Hoffbrand
Journal:  Lancet       Date:  1982-04-10       Impact factor: 79.321

6.  A multi-center, double-blind comparison of ketoconazole and griseofulvin in the treatment of infections due to dermatophytes.

Authors:  R Legendre; M Steltz
Journal:  Rev Infect Dis       Date:  1980 Jul-Aug

7.  Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial.

Authors:  E A Petersen; D W Alling; C H Kirkpatrick
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391

8.  Disposition of ketoconazole, an oral antifungal, in humans.

Authors:  C Brass; J N Galgiani; T F Blaschke; R Defelice; R A O'Reilly; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

9.  Oral ketoconazole. An effective and safe treatment for dermatophytosis.

Authors:  H E Jones; J G Simpson; W M Artis
Journal:  Arch Dermatol       Date:  1981-03
  9 in total
  2 in total

Review 1.  A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis.

Authors:  A K Gupta; N H Shear
Journal:  Drug Saf       Date:  2000-01       Impact factor: 5.606

2.  Non-suppression of cortisol secretion by long term treatment with ketoconazole in patients with acute leukaemia.

Authors:  P Dandona; J Mohiuddin; H G Prentice
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.